About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Enter your email address:

Delivered by FeedBurner

Subscribe to this blog's feed

Contact the Docs

Docs on Twitter


Recent Posts

Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« AstraZeneca Announces Acquisition of MedImmune | Main | USPTO's Advice Concerning Priority Document Exchange (PDX) Program »

April 24, 2007

Seton Hall Establishes Center for Health & Pharmaceutical Law

    By Mark Chael --

Seton_hall_law_logo On Friday, April 27, 2007 at 9:00 am, the Seton Hall University School of Law (SHU Law) will hold a press conference to announce the establishment of the Center for Health & Pharmaceutical Law.  The mission of the new Center will be "to address the evolving legal and public policy framework of modern drug and device regulation and practice."

As reported by the Associated Press, the Center will be funded primarily by endowments totaling more than $8 million from Bristol-Myers Squibb, Johnson & Johnson, Sanofi-Avenis, and Schering-Plough.  Bristol-Myers Squibb itself will be donating $5 million to endow a professorship in corporate governance and business.

The research and policy center will focus on various issues affecting the pharmaceutical and medical device industries, including legal, business ethics, regulatory, enforcement, among others.  According to Ms. Denise Pinney, who is the Assistant Dean of Health, Science, and Technology Law at SHU Law, the research will include not only the view of industry personnel and legal scholars, but also the views of patients, doctors, politicians, and students.

More information about the press conference can be found here.

Posted at 10:19 PM in Biotech/Pharma News |

Comments

The comments to this entry are closed.

March 2020

Sun Mon Tue Wed Thu Fri Sat
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31        

Categories

Archives

More...